Latest Articles
Portopulmonary hypertension: A focused review for the internistKey aspects of screening, diagnosis, and treatment, and a review of the various pulmonary hemodynamic patterns encountered in patients with liver disease.
- Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
These conditions often co-exist and can have complex interactions. The progression of kidney disease increases the risk of major adverse cardiovascular events.
- Evaluating a low anion gap: A practical approach
In teaching and in practice, little attention is given to a low anion gap, an oversight that can result in a missed opportunity to diagnose acute or chronic disorders requiring treatment.
- Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?
Research and robust data are still lacking regarding use of midodrine in this setting.
- vOka vaccine-associated disseminated varicella zoster
The patient had received the live attenuated vaccine 1 month before presentation. He had no history of varicella infection.
- When should pharmacologic therapies be used for uremic pericarditis?
If symptoms return or fail to improve with renal replacement therapy, drug therapy may be considered.
- Should I consider metformin therapy for weight loss in patients with obesity but without diabetes?
The authors appraise the evidence to date for weight loss with metformin in this patient population.
